Publisher profile
npr.org
Explore recent coverage from this publisher, with reporting context brought together on Scroll News.
Reporting, in context
No article image available
A recent study caught our eye: salmon on cocaine. Or really, researchers giving salmon cocaine…for science. See, scientists know human drugs pollute aquatic environments – past studies have shown even anti-anxiety drugs can change how fish act. But illicit drugs are less studied. And Jack Brand, an aquatic ecologist at the Swedish University of Agricultural Sciences, wanted to know how illicit drugs like cocaine might change fish behavior, like foraging and mating. To answer that question, Jack and his team gave salmon cocaine. Interested in more science? Email us your question at shortwave@npr.org.Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.
In a filing, ABC accuses the Trump administration of trying to chill its constitutionally protected free speech. The point of contention: "The View," and whether it's subject to equal time rules.
Pollinators have economic and health benefits, but those benefits have been difficult to quantify. A new study puts some numbers to how important pollinators are for both nutrition and income.
President Trump recently signed an order to speed up the evaluation of psychedelics to treat the brain. That’s coming after decades of strict prohibition on psychedelic drug use dating back to President Nixon. So how did we go from that to a psychedelic renaissance? A look into a key institution in the world of psychedelic research may give us some clues. This episode, NPR’s brain correspondent Jon Hamilton shares insight from a recent trip. (No pun intended.) Want more psychedelic content? Catch our episode on ketamine therapy here, or learn why some scientists want to take the trip out of psychedelics here. Have other questions about psychedelics and the brain? Let us know by emailing shortwave@npr.org!
Follow a story across time
Explore editorial and community perspectives on connected reporting.
Distinct perspectives · No trails available yet
Publisher-associated editorial trails will appear here when an editorial publishing workflow is available.
Public reader-created trails featuring this publisher's coverage are not shown until privacy-safe discovery is available.
Explore the reporting
Browse recurring subjects across this publisher's coverage.
Publisher-specific topics
Topic discovery is not available for this publisher yet.